The adoption of centralized monitoring by CROs with Jennifer Stewart

Sylvain Berthelot welcomes Jennifer Stewart, Vice President AI and Innovation at Premier Research and an active member of ACRO’s Risk-Based Quality Management (RBQM) working group. Together, they explore the current state of RBQM adoption and what it will take for the industry to fully embrace risk-based approaches in clinical trials.

Drawing on insights from ACRO’s annual industry survey, Jennifer shares a candid view of where progress is being made, and where challenges remain. While awareness of RBQM is high, true adoption is still inconsistent, with many organisations implementing elements in isolation rather than as a fully integrated strategy. She explains how this partial adoption limits the overall impact on trial quality and efficiency.

Sylvain and Jennifer discuss the key barriers holding the industry back, from persistent reliance on traditional practices like 100% SDV to misconceptions about regulatory expectations. They also highlight the growing role of regulators in encouraging risk-based approaches and why clearer communication and industry confidence are critical to driving change.

Tune in to explore how RBQM is evolving, what the latest data tells us about adoption trends, and why shifting mindset – not just technology – is essential to unlocking its full potential.

Watch the full webinar

Share via

See CRScube in action

Book a demo

Explore how our platform will elevate your team and clinical trial management.

Get insights straight to your inbox

Explore our knowledge base

Stay in-the-know with regular updates and industry opinions from our expert team.

See all resources

Featured resources

The reality of data fragmentation in clinical trials with Kavita Gaadhe

Why clinical teams transition from legacy systems to CRScube

As the industry moves toward faster, more decentralized models, many teams find that the tools which once supported them now require significant manual workarounds to stay current.

From "Wow" to "How": What your questions taught us about the future of AI in clinical trials

While presenting our AI-led EDC setup functionality, we were impressed by the questions asked and what they reveal about our clients' readiness for AI-driven technology.